ORPHINA
Dead / Abandoned — Abandoned — failure to respond (as of 02 Jun 2021)
What this means for you
This application is over — abandoned 13 May 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90076663
- Mark type
- Stylized text
- Filed
- 27 Jul 2020
- Abandoned
- 13 May 2021
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of neuromuscular, neurological, musculoskeletal, genetic, metabolic, orthopedic, and oncologic diseases; Pharmaceutical preparations for the prevention of rare diseases; Pharmaceutical preparations for the prevention of muscle wasting and muscle degeneration; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of neuromuscular, neurological, musculoskeletal, genetic, metabolic, orthopedic, and oncologic diseases; Pharmaceutical preparations for the treatment of rare diseases; Pharmaceutical preparations for the treatment of muscle wasting and muscle degeneration; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for biologics, gene therapy, or stem cell therapy; Pharmaceutical preparations for muscle function improvement; Stem cells for medical purposes
Owner
- Orphina LLC, Calabasas, CA, US
Prosecution history
- 02 Jun 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 02 Jun 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 12 Nov 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Nov 2020 — NON-FINAL ACTION E-MAILED
- 12 Nov 2020 — NON-FINAL ACTION WRITTEN
- 12 Nov 2020 — ASSIGNED TO EXAMINER
- 26 Aug 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Jul 2020 — NEW APPLICATION ENTERED